THC director trade: 2,500 shares sold; 8,792 shares remain
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tenet Healthcare (THC) reported an insider transaction by a director. On 10/29/2025, the director sold 2,500 shares of common stock at $208.43 per share. After this sale, the director beneficially owns 8,792 shares, held directly.
The filing lists the reporting person as Richard W. Fisher, with the form signed by attorney-in-fact Chad J. Wiener on 10/31/2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,500 shares ($521,075)
Net Sell
1 txn
Insider
FISHER RICHARD W
Role
Director
Sold
2,500 shs ($521K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,500 | $208.43 | $521K |
Holdings After Transaction:
Common Stock — 8,792 shares (Direct)
Footnotes (1)
FAQ
What insider trade did THC report?
A director sold 2,500 shares of Tenet Healthcare common stock at $208.43 on 10/29/2025.
What was the transaction code on the Form 4 for THC?
The transaction code was S, indicating an open market or private sale.
Who is the reporting person in this THC Form 4?
The reporting person is Richard W. Fisher, a director of Tenet Healthcare.
Who signed the THC Form 4 and when?
It was signed by Chad J. Wiener, attorney-in-fact for Richard W. Fisher, on 10/31/2025.
What is the ownership form after the sale?
The shares are reported as Direct (D) ownership.